With the exception of clinical trials, psychedelic therapy is currently performed underground or under nebulous legality. As demand soars, a handful of countries in Latin America, including Costa Rica, Jamaica and Mexico, have become hubs for experimental protocols and clinical studies.
Understand Post-Traumatic Stress Disorder
The invasive symptoms of PTSD can affect combat veterans and civilians alike. Early intervention is critical for managing the condition.
Dr. Polanco, who is not licensed in the United States, has been practicing on the fringes of mainstream medicine for years, but his work is now drawing interest from more established specialists in mental health. Later this year, researchers at the University of Texas at Austin and Baylor University intend to examine his protocols in two clinical studies.
The use of psychedelic treatments is not currently part of the standard of care for treatment of mental health conditions at Veterans Hospitals, according to Randal Noller, a spokesman for the Veterans Affairs Department. But with special approval, it is possible they could be administered as part of a research protocol, and the department’s Office of Mental Health and Suicide Prevention is “closely monitoring the developing scientific literature in this area,” Mr. Noller said.
In Mexico, two of the substances that Dr. Polanco administers — ibogaine, a plant-based psychoactive commonly used to treat addiction, and 5-MeO-DMT, a powerful hallucinogen derived from the poison of the Sonoran desert toad — are neither unlawful nor approved for medical use. The third, psilocybin mushrooms, may be taken legally in ceremonies that follow Indigenous traditions.
During the course of a weekend retreat, Dr. Polanco’s patients start on Saturday with a ceremony using either ibogaine or psilocybin. The initial trip is intended to trigger disruptive thinking and deep introspection.